Imatib Imatinib 400 Mg tablet

Imatib Imatinib 400 Mg tablet works by binding to the "ATP-binding site" of the BCR-ABL enzyme. By occupying this site, it prevents the enzyme from turning on the growth signals that cause white blood cells to grow uncontrollably.

Key Clinical Benefits

• High Response Rates: Clinical studies show that up to 90% of CML patients achieve normal blood cell counts within months of starting Imatinib therapy.

• Targeted Action: Minimizes damage to healthy cells compared to standard chemotherapy, leading to fewer systemic side effects.

• Long-Term Control: Designed for chronic use, it can keep cancer in a "molecularly undetectable" state for many years.

• Versatility: Effective against multiple rare conditions, including Dermatofibrosarcoma Protuberans (DFSP) and Hypereosinophilic Syndrome (HES).

Administration & Safety Protocols

1. With Food: IMATIB should always be taken with a meal and a large glass of water (200mL) to minimize stomach irritation and nausea.

2. Swallow Whole: Do not crush or chew the tablets. If you have difficulty swallowing, the tablet can be dissolved in a glass of water or apple juice (stir until dissolved and drink immediately).

3. Consistency: Take your dose at the same time every day to keep a steady level of the medicine in your blood.

4. Avoid Grapefruit: Do not consume grapefruit or grapefruit juice, as it can significantly increase the levels of Imatinib in your body and cause toxicity.

5. Monitoring: Regular blood tests (Complete Blood Count and Liver Function Tests) are essential to monitor your response and manage potential side effects like bone marrow suppression.